{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:15:19Z","timestamp":1791288919084,"version":"4.3.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.beem.2010.10.006","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T06:01:49Z","timestamp":1291096909000},"page":"907-914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Carney complex and other conditions associated with micronodular adrenal hyperplasias"],"prefix":"10.1016","volume":"24","author":[{"given":"Madson Q.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2010.10.006_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.beem.2010.10.006_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1085-5629(05)80003-3","article-title":"Carney complex: the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas","volume":"14","author":"Carney","year":"1995","journal-title":"Semin. Dermatol."},{"key":"10.1016\/j.beem.2010.10.006_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CCO.0b013e32801195eb","article-title":"Carney complex: the first 20 years","volume":"19","author":"Boikos","year":"2007","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.beem.2010.10.006_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0190-9622(84)80047-X","article-title":"Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: the \u201cLAMB\u201d syndrome","volume":"10","author":"Rhodes","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.beem.2010.10.006_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.1980.tb07266.x","article-title":"A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome","volume":"103","author":"Atherton","year":"1980","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.beem.2010.10.006_bib6","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2019-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib7","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000095527","article-title":"Carney complex: pathology and molecular genetics","volume":"83","author":"Boikos","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2010.10.006_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1755-148X.2009.00613.x","article-title":"Carney complex and lentiginosis","volume":"22","author":"Horvath","year":"2009","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.beem.2010.10.006_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.beem.2010.10.006_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaad.2008.07.032","article-title":"Heterogeneity of skin manifestations in patients with carney complex","volume":"59","author":"Mateus","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.beem.2010.10.006_bib12","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1210\/jc.2004-0055","article-title":"Hypodense nodularity on computed tomography: novel imaging and pathology of micronodular adrenocortical hyperplasia associated with myelolipomatous changes","volume":"89","author":"Courcoutsakis","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-131-8-199910190-00006","article-title":"Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease","volume":"131","author":"Stratakis","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.beem.2010.10.006_bib14","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1210\/jc.2009-0031","article-title":"The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits","volume":"94","author":"Louiset","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib15","first-page":"3860","article-title":"Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the \u201ccomplex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas\u201d (Carney complex)","volume":"85","author":"Pack","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1515\/JPEM.2000.13.4.374","article-title":"Prolactin secretion abnormalities in patients with the \u201csyndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas\u201d (Carney complex)","volume":"13","author":"Raff","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib17","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1210\/jcem.82.7.4079","article-title":"Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex)","volume":"82","author":"Stratakis","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1097-0096(199705)25:4<211::AID-JCU10>3.0.CO;2-N","article-title":"Testicular ultrasound in carney complex: report of three cases","volume":"25","author":"Premkumar","year":"1997","journal-title":"J. Clin. Ultrasound"},{"key":"10.1016\/j.beem.2010.10.006_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00000478-199003000-00002","article-title":"Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the cushing syndrome","volume":"14","author":"Carney","year":"1990","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.beem.2010.10.006_bib20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI118467","article-title":"Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2","volume":"97","author":"Stratakis","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.beem.2010.10.006_bib21","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.CIR.98.23.2560","article-title":"Identification of a novel genetic locus for familial cardiac myxomas and carney complex","volume":"98","author":"Casey","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2010.10.006_bib22","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1172\/JCI10841","article-title":"Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and carney complex","volume":"106","author":"Casey","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.beem.2010.10.006_bib23","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/hmg\/9.20.3037","article-title":"Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex","volume":"9","author":"Kirschner","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.beem.2010.10.006_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.molcel.2006.09.015","article-title":"A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase","volume":"24","author":"Kinderman","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.beem.2010.10.006_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1040-7952(97)80019-5","article-title":"Structure, function, and regulation of human cAMP-dependent protein kinases","volume":"31","author":"Tasken","year":"1997","journal-title":"Adv. Second Messenger Phosphoprotein Res."},{"key":"10.1016\/j.beem.2010.10.006_bib26","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/en.2004-0900","article-title":"Minireview: PRKAR1A: normal and abnormal functions","volume":"145","author":"Bossis","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2010.10.006_bib27","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2005-2708","article-title":"A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds","volume":"91","author":"Groussin","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib28","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/ddg160","article-title":"Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1\/2","volume":"12","author":"Robinson-White","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.beem.2010.10.006_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/1078-0432.CCR-07-1155","article-title":"Large deletions of the PRKAR1A gene in carney complex","volume":"14","author":"Horvath","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.beem.2010.10.006_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/humu.20688","article-title":"In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay","volume":"29","author":"Greene","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.beem.2010.10.006_bib31","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1158\/0008-5472.CAN-08-0064","article-title":"Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors","volume":"68","author":"Meoli","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.beem.2010.10.006_bib32","doi-asserted-by":"crossref","first-page":"14222","DOI":"10.1073\/pnas.0405535101","article-title":"Comparative PRKAR1A genotype-phenotype analyses in humans with carney complex and prkar1a haploinsufficient mice","volume":"101","author":"Veugelers","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.beem.2010.10.006_bib33","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/344579","volume":"71","author":"Groussin","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.beem.2010.10.006_bib34","article-title":"Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families","author":"Pereira","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mce.2008.11.010","article-title":"New genes and\/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors","volume":"300","author":"Stratakis","year":"2009","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.beem.2010.10.006_bib36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng1809","article-title":"A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia","volume":"38","author":"Horvath","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.beem.2010.10.006_bib37","doi-asserted-by":"crossref","first-page":"11571","DOI":"10.1158\/0008-5472.CAN-06-2914","article-title":"Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population","volume":"66","author":"Horvath","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.beem.2010.10.006_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-2008-1076694","article-title":"Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions","volume":"40","author":"Boikos","year":"2008","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.beem.2010.10.006_bib39","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJMc0706182","article-title":"Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia","volume":"358","author":"Horvath","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.beem.2010.10.006_bib40","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1158\/0008-5472.CAN-05-0580","article-title":"A mouse model for the carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues","volume":"65","author":"Kirschner","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.beem.2010.10.006_bib41","doi-asserted-by":"crossref","first-page":"10603","DOI":"10.1158\/0008-5472.CAN-06-2200","article-title":"PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes","volume":"66","author":"Robinson-White","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.beem.2010.10.006_bib42","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2006-0188","article-title":"PRKAR1A mutations and protein kinase a interactions with other signaling pathways in the adrenal cortex","volume":"91","author":"Robinson-White","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib43","doi-asserted-by":"crossref","first-page":"10307","DOI":"10.1158\/0008-5472.CAN-05-3183","article-title":"Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins","volume":"65","author":"Nadella","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.beem.2010.10.006_bib44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1210\/jc.2007-1902","article-title":"An immortalized human cell line bearing a PRKAR1A-inactivating mutation: effects of overexpression of the wild-type Allele and other protein kinase A subunits","volume":"93","author":"Nesterova","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib45","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1158\/0008-5472.CAN-09-1601","article-title":"Inactivation of the carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells","volume":"69","author":"Ragazzon","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.beem.2010.10.006_bib46","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/sj.onc.1207277","article-title":"Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators","volume":"23","author":"Bourdeau","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2010.10.006_bib47","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1210\/jc.2005-1301","article-title":"Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation","volume":"91","author":"Horvath","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.2008.03273.x","article-title":"Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)","volume":"69","author":"Tadjine","year":"2008","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.beem.2010.10.006_bib49","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1210\/jc.2008-0631","article-title":"Wnt\/beta-catenin and 3\u2019,5\u2019-cyclic adenosine 5\u2019-monophosphate\/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors","volume":"93","author":"Gaujoux","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.beem.2010.10.006_bib50","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1158\/0008-5472.CAN-09-0155","article-title":"MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling","volume":"69","author":"Iliopoulos","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.beem.2010.10.006_bib51","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/hmg\/ddq014","article-title":"Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+\/\u2212 or Rb1+\/\u2212 backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling","volume":"19","author":"Almeida","year":"2010","journal-title":"Hum. Mol. Genet."}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X10001338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X10001338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:43:14Z","timestamp":1761496994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X10001338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1521690X10001338"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2010.10.006","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carney complex and other conditions associated with micronodular adrenal hyperplasias","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2010.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}